Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aidoc, Celecor, Cercare, Deephealth, Gilead, Ionis, Merck, Pfizer, Radnet, Reprocell, Spectral, Sunshine.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Brightheart, Hepquant, Life, Merck, Natera, Valgen.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Arrowhead, Biokin, Calico, China Medical System, Diasorin, Draeger, ECM, Gilead, Lem, Orion, Portal, Quoin, Sanofi, Spotlight, Systimmune, US Worldmeds.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Achieve, Carsgen, Exeltis USA, Incyte, Masimo, Merz, Moderna, Novo Nordisk, Praxis, Regeneron, Sanofi, Sumitomo, Teijin, Tetmedical, Teva, Viiv.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Iaso, Qihan, Zai Lab.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Corcept, E-Scopics, GRI, GSK, Iaso, Merck, Roche, Spero.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Fibersense, Sernova, Uniqure, Vygon, Xaga.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Gilead, Inhibrx, Novabridge, Outlook, Qihan, SK, Surgentec, Zai Lab.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alk, Astrazeneca, Bayer, Belite, Guardant, Merck, Precigen, Roche, Sanofi.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Oncolys, Pharmaessentia, Remegen, Takeda, Vcare, Vor, Zai Lab.